CD34 and Splenomegaly: In JAK2-mutated patients, the TT genotype was associated with more severe disease at diagnosis, i.e., reduced platelet count, increased lactate dehydrogenase in plasma, massive splenomegaly, high number of CD34+ cells in blood, lower cholesterol concentration, and a higher inflammatory background as indicated by the hs-CRP-elevated plasmatic level.